Results 41 to 50 of about 11,011 (206)

Inhaled formoterol impairs aerobic exercise capacity in endurance-trained individuals: a randomised controlled trial

open access: yesERJ Open Research, 2023
Background The 2022 Global Initiative for Asthma guidelines emphasise the inhaled long-acting β2-agonist formoterol as part of the first treatment step, and therefore formoterol use among athletes will probably increase.
Søren Jessen   +7 more
doaj   +1 more source

Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study

open access: yesRespiratory Research, 2010
Background The budesonide/formoterol combination is successfully used for fast relief of asthma symptoms in addition to its use as maintenance therapy.
van der Woude Hanneke J   +3 more
doaj   +1 more source

A Solid-state NMR Study of Formoterol Fumarate [PDF]

open access: yes, 2009
Spectra have been obtained for each of the three formoterol fumarate solvates diethanol, diisopropanol and dibenzyl alcohol and, with the aid of solution-state data and dipolar dephasing experiments, carbon-13 spectral assignments have been made.
Markwell, Andrew Fraser
core  

Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events (Review)

open access: yes, 2009
Background Epidemiological evidence has suggested a link between beta2-agonists and increases in asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta2-agonists are ...
Christopher J Cates   +5 more
core   +1 more source

Malignancy in Pediatric Hyperfunctioning Thyroid Nodules: A Case Report and Literature Review

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Background Thyroid nodules are rare in children but carry a markedly higher risk of malignancy compared to adults (20%–26% vs. 5%). Hyperfunctioning thyroid nodules are exceptionally uncommon in the pediatric population and are typically benign.
Cristina Clausi   +12 more
wiley   +1 more source

PECULIARITIES OF THERAPY WITH LONG ACTING β2-ADRENERGIC AGONISTFORMOTEROL FOR ASTHMA IN CHILDREN

open access: yesПедиатрическая фармакология, 2006
Information on clinical use of long acting β2-adrenergic agonist formoterol in children with asthma is presented. Pharmacokinetics and pharmacodymanics are scrutinized in detail.
Yu.G. Levina   +5 more
doaj   +2 more sources

Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children (Review)

open access: yes, 2009
Background Traditionally inhaled treatment for asthma has been considered as preventer and reliever therapy. The combination of formoterol and budesonide in a single inhaler introduces the possibility of using a single inhaler for both prevention and ...
Christopher J Cates   +3 more
core   +1 more source

Parasomnias and sleep‐related movement disorders induced by drugs in the adult population: a review about iatrogenic medication effects

open access: yesJournal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont   +5 more
wiley   +1 more source

Clinical pharmacology and prescribing education: An updated medical school curriculum from the British Pharmacological Society

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 6, Page 1787-1808, June 2026.
Aims Prescribing is a complex, essential skill that doctors must acquire to practice medicine safely and effectively. The British Pharmacological Society has historically provided a core curriculum to guide clinical pharmacology and prescribing education in UK medical schools.
Dagan O. Lonsdale   +5 more
wiley   +1 more source

Non-interventional study of the safety and effectiveness of fluticasone propionate/formoterol fumarate in real-world asthma management

open access: yesTherapeutic Advances in Respiratory Disease, 2018
Introduction: In recognition of the value of long-term real-world data, a postauthorization safety study of the inhaled corticosteroid (ICS) fluticasone propionate and long-acting β 2 -agonist (LABA) formoterol fumarate (fluticasone/formoterol; Flutiform
Vibeke Backer   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy